CLINICAL_TRIALS
research
· 2025-09-05
Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS [Phase 2]
Summary
A Phase 2 clinical trial is evaluating the safety, tolerability, and pharmacology of darifenacin in patients with amyotrophic lateral sclerosis, currently recru…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oliver Blanchard | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: RECRUITING